Analysis of changes in the chemokine CXC ligand 13 in serum and cerebrospinal fluid of patients with neuromyelitis optica
Abstract To determine correlation between the Extended Disability Status Scale(EDSS) grade and the progression of neuromyelitis optica(NMO) patients’ levels of the chemokine CXC ligand 13 (CXCL13) in their serum and cerebrospinal fluid. This research included forty-one patients diagnosed with neurom...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-85650-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832594817123614720 |
|---|---|
| author | Juan Zhou Shalin Luo Xiaoxi Yao Haipeng Li Ying Wen |
| author_facet | Juan Zhou Shalin Luo Xiaoxi Yao Haipeng Li Ying Wen |
| author_sort | Juan Zhou |
| collection | DOAJ |
| description | Abstract To determine correlation between the Extended Disability Status Scale(EDSS) grade and the progression of neuromyelitis optica(NMO) patients’ levels of the chemokine CXC ligand 13 (CXCL13) in their serum and cerebrospinal fluid. This research included forty-one patients diagnosed with neuromyelitis optica(NMO) and forty-three patients diagnosed with multiple sclerosis(MS). The control group consisted of forty-three non-inflammatory neurological disease(NND) patients. The patients’ serum and cerebrospinal fluid CXCL13 levels were measured. Patients in NMO group and MS group had serum and cerebrospinal fluid with CXCL13 levels that were substantially greater than those in the NND group. When comparing the CXCL13 levels of blood and cerebrospinal fluid between patients in the EDSS ≥ 3.5 group and the EDSS<3.5 group, with the EDSS ≥ 3.5 group’s CXCL13 levels being greater(P<0.05). There was a positive correlation between the serum CXCL13 and the EDSS grades of both the NMO and MS groups(r = 0.884, P < 0.001); The cerebrospinal fluid CXCL13 of the NMO and MS groups showed a positive correlation with their EDSS grades(r = 0.681, P < 0.001). EDSS scores of NMO patients were positively correlated with their serum BLC-1 (r = 0.896, P < 0.001); EDSS scores of NMO patients were positively correlated with their cerebrospinal fluid BLC-1 (r = 0.678, P < 0.001).EDSS scores of MS patients were positively correlated with their serum BLC-1 (r = 0.852, P < 0.001); EDSS scores of MS patients were positively correlated with their cerebrospinal fluid BLC-1 (r = 0.613, P < 0.001). Serum and cerebrospinal fluid levels of CXCL13 may serve as an important biomarker for the presumptive assessment of the degree of disability in NMO and MS disease, providing a basis for the treatment and control of the disease. |
| format | Article |
| id | doaj-art-2c5c8bfadf6547fdaee23c2bb3db3cce |
| institution | Kabale University |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-2c5c8bfadf6547fdaee23c2bb3db3cce2025-01-19T12:18:45ZengNature PortfolioScientific Reports2045-23222025-01-011511810.1038/s41598-025-85650-7Analysis of changes in the chemokine CXC ligand 13 in serum and cerebrospinal fluid of patients with neuromyelitis opticaJuan Zhou0Shalin Luo1Xiaoxi Yao2Haipeng Li3Ying Wen4Department of Neurology, Chenzhou First People’s HospitalDepartment of Neurology, Chenzhou First People’s HospitalDepartment of Neurology, Chenzhou First People’s HospitalDepartment of Neurology, Chenzhou First People’s HospitalDepartment of Neurology, Chenzhou First People’s HospitalAbstract To determine correlation between the Extended Disability Status Scale(EDSS) grade and the progression of neuromyelitis optica(NMO) patients’ levels of the chemokine CXC ligand 13 (CXCL13) in their serum and cerebrospinal fluid. This research included forty-one patients diagnosed with neuromyelitis optica(NMO) and forty-three patients diagnosed with multiple sclerosis(MS). The control group consisted of forty-three non-inflammatory neurological disease(NND) patients. The patients’ serum and cerebrospinal fluid CXCL13 levels were measured. Patients in NMO group and MS group had serum and cerebrospinal fluid with CXCL13 levels that were substantially greater than those in the NND group. When comparing the CXCL13 levels of blood and cerebrospinal fluid between patients in the EDSS ≥ 3.5 group and the EDSS<3.5 group, with the EDSS ≥ 3.5 group’s CXCL13 levels being greater(P<0.05). There was a positive correlation between the serum CXCL13 and the EDSS grades of both the NMO and MS groups(r = 0.884, P < 0.001); The cerebrospinal fluid CXCL13 of the NMO and MS groups showed a positive correlation with their EDSS grades(r = 0.681, P < 0.001). EDSS scores of NMO patients were positively correlated with their serum BLC-1 (r = 0.896, P < 0.001); EDSS scores of NMO patients were positively correlated with their cerebrospinal fluid BLC-1 (r = 0.678, P < 0.001).EDSS scores of MS patients were positively correlated with their serum BLC-1 (r = 0.852, P < 0.001); EDSS scores of MS patients were positively correlated with their cerebrospinal fluid BLC-1 (r = 0.613, P < 0.001). Serum and cerebrospinal fluid levels of CXCL13 may serve as an important biomarker for the presumptive assessment of the degree of disability in NMO and MS disease, providing a basis for the treatment and control of the disease.https://doi.org/10.1038/s41598-025-85650-7Neuromyelitis opticaB lymphocyte chemotactic factor-1Cerebrospinal fluid |
| spellingShingle | Juan Zhou Shalin Luo Xiaoxi Yao Haipeng Li Ying Wen Analysis of changes in the chemokine CXC ligand 13 in serum and cerebrospinal fluid of patients with neuromyelitis optica Scientific Reports Neuromyelitis optica B lymphocyte chemotactic factor-1 Cerebrospinal fluid |
| title | Analysis of changes in the chemokine CXC ligand 13 in serum and cerebrospinal fluid of patients with neuromyelitis optica |
| title_full | Analysis of changes in the chemokine CXC ligand 13 in serum and cerebrospinal fluid of patients with neuromyelitis optica |
| title_fullStr | Analysis of changes in the chemokine CXC ligand 13 in serum and cerebrospinal fluid of patients with neuromyelitis optica |
| title_full_unstemmed | Analysis of changes in the chemokine CXC ligand 13 in serum and cerebrospinal fluid of patients with neuromyelitis optica |
| title_short | Analysis of changes in the chemokine CXC ligand 13 in serum and cerebrospinal fluid of patients with neuromyelitis optica |
| title_sort | analysis of changes in the chemokine cxc ligand 13 in serum and cerebrospinal fluid of patients with neuromyelitis optica |
| topic | Neuromyelitis optica B lymphocyte chemotactic factor-1 Cerebrospinal fluid |
| url | https://doi.org/10.1038/s41598-025-85650-7 |
| work_keys_str_mv | AT juanzhou analysisofchangesinthechemokinecxcligand13inserumandcerebrospinalfluidofpatientswithneuromyelitisoptica AT shalinluo analysisofchangesinthechemokinecxcligand13inserumandcerebrospinalfluidofpatientswithneuromyelitisoptica AT xiaoxiyao analysisofchangesinthechemokinecxcligand13inserumandcerebrospinalfluidofpatientswithneuromyelitisoptica AT haipengli analysisofchangesinthechemokinecxcligand13inserumandcerebrospinalfluidofpatientswithneuromyelitisoptica AT yingwen analysisofchangesinthechemokinecxcligand13inserumandcerebrospinalfluidofpatientswithneuromyelitisoptica |